Health-Related Quality of Life in Gay Men With Localized Prostate Cancer

Patient-Reported Outcomes For Gay Men With Localized Prostate Cancer

RATIONALE: Gathering information about prostate cancer, treatment, and quality of life from gay men with prostate cancer may help doctors plan the best treatment.

PURPOSE: This clinical trial is collecting information about health-related quality of life from gay men with localized prostate cancer.

Study Overview

• Status: Completed
• Conditions: Prostate Cancer

Detailed Description

OBJECTIVES:

• To enroll 200 gay men with localized prostate cancer in a cross-sectional study of prostate cancer outcomes.
• To complete an R01 application using pilot data collected from these patients.
• To complete manuscripts describing the factors that influence quality of life and treatment satisfaction in these patients.

OUTLINE: Patients complete a web-based survey about their disease (biopsy Gleason score, PSA at diagnosis, and T-stage), treatment (treatment type, time since treatment, and use of healthcare services [e.g., oral medications for erectile dysfunction]), symptom distress, and psychosocial factors (ethnicity, health literacy, level of social support, communication with provider, relationship status, and communication with partner) that affect their health-related quality of life. The data will be used to provide the information necessary to tailor an existing prostate cancer survivorship intervention to address the specific needs of gay men with prostate cancer.

• Study Type: Observational
• Enrollment (Actual): 92

Contacts and Locations

Study Locations

• Canada
  • Ontario
    • Toronto, Ontario, Canada, M5B 2K3
      • Ryerson University
• United States
  • Texas
    • Houston, Texas, United States, 77030
      • Veterans Affairs Medical Center - Houston
    • Houston, Texas, United States, 77030
      • Dan L. Duncan Cancer Center at Baylor College of Medicine

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 100 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Male

• Sampling Method: Non-Probability Sample

Study Population

Convenience sample contacted via Internet

Description

DISEASE CHARACTERISTICS:

• Diagnosis of localized prostate cancer

  • No advanced disease
• Self-identified as gay

PATIENT CHARACTERISTICS:

• Able to complete an online questionnaire
• Able to speak and understand English

PRIOR CONCURRENT THERAPY:

• Not specified

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Effect of disease factors and treatment factors on subjective well-being	Cross-sectional retrospective study, one timepoint
Effect of disease factors and treatment factors on illness intrusiveness	Cross-sectional retrospective study, one timepoint
Effect of psychosocial factors on subjective well-being	Cross-sectional retrospective study, one timepoint

Collaborators and Investigators

• Sponsor: Baylor College of Medicine
• Investigators: Principal Investigator: David M. Latini, PhD, Baylor College of Medicine

Study record dates

Study Major Dates

• Study Start: August 1, 2008
• Primary Completion (Actual): December 1, 2010
• Study Completion (Actual): June 1, 2015

Study Registration Dates

• First Submitted: January 23, 2009
• First Submitted That Met QC Criteria: January 23, 2009
• First Posted (Estimate): January 26, 2009

Study Record Updates

• Last Update Posted (Actual): January 23, 2018
• Last Update Submitted That Met QC Criteria: January 18, 2018
• Last Verified: January 1, 2018

More Information

Terms related to this study

• Keywords: stage I prostate cancer; stage II prostate cancer
• Additional Relevant MeSH Terms: Neoplasms; Urogenital Neoplasms; Neoplasms by Site; Genital Neoplasms, Male; Prostatic Diseases; Prostatic Neoplasms
• Other Study ID Numbers: CDR0000600597; BCM-H-21892 (Other Identifier: Baylor College of Medicine)